Archives: Agenda

• Clinical contracting is on the critical path to trial start
• It is a process where bottlenecks and root causes can be identified via data analysis
• Lean Six Sigma methodology can help to significantly reduce contracting lead-time

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!

Visit our exhibitors’ booths throughout the conference and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!

• Learn how to pressure-test site footprint through predictive analytics by forecasting enrollment at the country and site level
• Discover methods to run re-forecasts based on actual study performance for more accurate tracking and adjustments as necessary
• Gain competitive advantage thru actionable insights to remain agile and avoid costly enrollment delays
• Learn how to leverage data to identify low-performing sites earlier in the trial process to implement effective risk mitigation tactics

• The UAE as a prominent hub for research and clinical trials, driven by a focus on healthcare innovation and patient-centric approaches
• The UAE’s comprehensive regulatory framework that supports and facilitates clinical research
• Training and upskilling local researchers and clinicians in research methodologies
• Prioritizing patient-centric approach, engaging patient communities and advocacy groups

Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!

• Challenges and limitations of rare disease research: how new solutions can help to overcome this
• Embracing a patient centric approach in rare disease trials through digital health
• Opportunities for innovation for orphan drug trials in the US

• Learn about a new comprehensive approach to assessing RBQM adoption
• See recent data on current and future levels of RBQM adoption among industry sponsors and CROs
• Discuss a maturity model that characterizes levels of adoption among industry sponsors
• Discuss perceived challenges associated with the implementation of RBQM components
• Discuss opportunities and benefits of RBQM implementation